← Back to Analyst Consensus 
RXST Hold
RxSight, Inc.
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (7 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 22, 2026 | Jefferies | maintain | Hold → Hold | — | 51% |
| Sep 22, 2026 | B of A Securities | maintain | Underperform → Underperform | — | 53% |
| Aug 10, 2026 | Stifel | maintain | Hold → Hold | — | 53% |
| Aug 6, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 7, 2026 | B of A Securities | maintain | Underperform → Underperform | — | 53% |
| Jul 7, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| May 7, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 7, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Mar 9, 2026 | Stifel | maintain | Hold → Hold | — | 53% |
| Feb 26, 2026 | UBS | maintain | Neutral → Neutral | $9 | 54% |
| Feb 26, 2026 | Piper Sandler | maintain | Neutral → Neutral | $10 | 54% |
| Feb 26, 2026 | Needham | reiterate | Buy → Buy | $13 | 50% |
| Jan 20, 2026 | Piper Sandler | maintain | Neutral → Neutral | $11 | 54% |
| Dec 2, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $10 | 54% |
| Nov 6, 2025 | JP Morgan | maintain | Underweight → Underweight | $9 | 55% |
| Nov 6, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $10 | 54% |
| Nov 6, 2025 | Needham | maintain | Buy → Buy | $12 | 50% |
| Aug 8, 2025 | UBS | maintain | Neutral → Neutral | $8 | 54% |
| Aug 8, 2025 | Stifel | maintain | Hold → Hold | $8 | 53% |
| Aug 8, 2025 | Needham | maintain | Buy → Buy | $11 | 50% |
| Jul 15, 2025 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $9 | 54% |
| Jul 10, 2025 | Jefferies | downgrade | Buy → Hold | $9 | 51% |
| Jul 9, 2025 | B of A Securities | maintain | Underperform → Underperform | $9 | 53% |
| Jul 9, 2025 | Piper Sandler | maintain | Neutral → Neutral | $10 | 54% |
| Jul 9, 2025 | Stifel | maintain | Hold → Hold | $9 | 53% |
| Jul 9, 2025 | Wells Fargo | downgrade | Overweight → Equal-Weight | $9 | 54% |
| Jul 9, 2025 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| Jul 9, 2025 | Needham | reiterate | Buy → Buy | $22 | 50% |
| May 19, 2025 | Wells Fargo | upgrade | Equal-Weight → Overweight | $25 | 54% |
| Apr 15, 2025 | Piper Sandler | initiate | — → Neutral | $18 | 54% |
| Apr 9, 2025 | UBS | downgrade | Buy → Neutral | $16 | 54% |
| Apr 7, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $17 | 54% |
| Apr 4, 2025 | JP Morgan | downgrade | Overweight → Underweight | $17 | 55% |
| Apr 3, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $22 | 54% |
| Apr 3, 2025 | Needham | reiterate | Buy → Buy | $43 | 50% |
| Mar 21, 2025 | B of A Securities | maintain | Buy → Buy | $36 | 53% |
| Mar 19, 2025 | Stifel | maintain | Hold → Hold | $28 | 53% |
| Feb 26, 2025 | JP Morgan | maintain | Overweight → Overweight | $40 | 55% |
| Feb 26, 2025 | Stifel | maintain | Hold → Hold | $33 | 53% |
| Feb 26, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $35 | 54% |
| Feb 26, 2025 | Needham | reiterate | Buy → Buy | $43 | 50% |
| Jan 13, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $40 | 54% |
| Jan 13, 2025 | Stifel | maintain | Hold → Hold | $35 | 53% |
| Jan 13, 2025 | Needham | reiterate | Buy → Buy | $66 | 50% |
| Dec 20, 2024 | Stifel | downgrade | Buy → Hold | $40 | 53% |
| Dec 17, 2024 | Needham | reiterate | Buy → Buy | $66 | 50% |
| Dec 11, 2024 | Wells Fargo | downgrade | Overweight → Equal-Weight | $42 | 54% |
| Dec 6, 2024 | UBS | initiate | — → Buy | $52 | 54% |
| Oct 29, 2024 | Jefferies | initiate | — → Buy | $72 | 51% |
| Sep 13, 2024 | Needham | reiterate | Buy → Buy | $66 | 50% |
Price Target Trend
Apr 20, 2026 Oct 27, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days